Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Aminopyridine in Episodic Ataxia Type 2
NCT01543750Phase 2Withdrawn
- Sponsor
- University of California, Los Angeles
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in episodic ataxia type 2 (EA2), sponsored by University of California, Los Angeles. Status: withdrawn.
02
Drugs
dalfampridine
03
Conditions
episodic ataxia type 2 (EA2)
Beyond the preview
Go deeper on NCT01543750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543750.